Lawsuit Claims Zostavax Led To Shingles And Other Injuries
Lawsuit Claims Zostavax Led To Shingles And Other Injuries
Introduction
A woman and her husband filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania on June 21, against Merck & co., indicating that she developed a number of serious health problems due to the side effects of shingles vaccine including the shingles injury, the vaccine was designed to prevent.
According to the plaintiff, the defendant sold a dangerous vaccine injection for the prevention of shingles, which contained a version of the live virus that was not sufficiently weakened to prevent reactivation of the dormant virus in older adults. The lawsuit indicated that the plaintiff received a Zostavax injection for the prevention of shingles in December 2016. After receiving the vaccine, she developed sharp tingling, burning pain on her left shoulder and was diagnosed with shingles, vertigo, and postherpetic polyneuropathy.
Hundreds of similar Zostavax lawsuits are filed by individuals nationwide. Zostavax is replaced by a new Shingrix vaccine, which does not involve the use of live virus and is widely viewed as a safer product.
Zostavax litigation is centralized before U.S. District Judge Harvey Bartle III in the Eastern District of Pennsylvania under MDL No. 2848.
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…